Showing results (171-180 of 208) with videos related to
Sort By:
Pageof 21
Journal of the Neurological Sciences|May 9, 2009
Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegiaKirsten Svenstrup, Peter Bross, Pernille Koefoed, et al.American Journal of Human Genetics|January 20, 2015
CLPB variants associated with autosomal-recessive mitochondrial disorder with cataract, neutropenia, epilepsy, and methylglutaconic aciduriaCarol Saunders, Laurie Smith, Flemming Wibrand, et al.Gene|May 30, 2002
Genomic organization, transcript variants and comparative analysis of the human nucleoporin 155 (NUP155) geneXiuqing Zhang, Huanming Yang, Jun Yu, et al.Journal of Inherited Metabolic Disease|September 4, 2010
A comprehensive HADHA c.1528G>C frequency study reveals high prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in PolandDorota Piekutowska-Abramczuk, Rikke K J Olsen, Jolanta Wierzba, et al.Molecular Genetics and Metabolism|January 20, 2007
REMOVED: Short-chain acyl-CoA dehydrogenase gene mutation (319 C>T) presents with clinical heterogeneity and is candidate founder mutation in Ashkenazi Jewish populationIngrid Tein, Orly Elpeleg, Bruria Ben-Zeev, et al.Oncogene|December 17, 2024
Mitochondrial unfolded protein response-dependent β-catenin signaling promotes neuroendocrine prostate cancerJordan Alyse Woytash, Rahul Kumar, Ajay K Chaudhary, et al.American Journal of Infection Control|November 15, 2021
Clinical characteristics and symptom duration among outpatients with COVID-19Alexandra Lane, Krystal Hunter, Elizabeth Leilani Lee, et al.Journal of Medical Virology|March 3, 2025
Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVIDKristoffer Skaalum Hansen, Sofie Eg Jørgensen, Cagla Cömert, et al.Molecular Genetics and Metabolism|December 7, 2007
Short-chain acyl-CoA dehydrogenase gene mutation (c.319C>T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish originIngrid Tein, Orly Elpeleg, Bruria Ben-Zeev, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapyLianne Hu, Chaohong Fan, Peter Bross, et al.Pageof 21